Login / Signup

Cardioprotective Potential of an SGLT2 Inhibitor Against Doxorubicin-Induced Heart Failure.

Chang-Myung OhSungsoo ChoJi-Yong JangHyeongseok KimSukyung ChunMinkyung ChoiSangkyu ParkYoung-Guk Ko
Published in: Korean circulation journal (2019)
SGLT2 inhibitors have a protective effect in Dox-induced HF in mice. This implied that SGLT2 inhibitor therapy could be a good treatment strategy even in HF patients without diabetes.
Keyphrases